Protagonist Therapeutics, Inc.
PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES

Last updated:

Abstract:

The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.

Status:
Application
Type:

Utility

Filling date:

13 Dec 2021

Issue date:

11 Aug 2022